Home » Topics » BioWorld Science

BioWorld Science
RSS

Human lactoferrin produced in transgenic animals

March 15, 1996

UR-9751 dropped from development

March 15, 1996

Antipsoriatic treatment in development at Immune Response

March 15, 1996

Human Genome Sciences claims novel wound-healing agents

March 15, 1996

Zeneca acquires antimigraine drug

March 15, 1996

Abbott and Purdue Pharma to copromote analgesic

March 15, 1996

Hoechst Marion Roussel claims new analgesics

March 13, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Biogen AD drug shows tau, cognition benefit, despite trial miss
BioWorld
Biogen Inc. has decided to advance diranersen (BIIB-080) into registrational trials for early Alzheimer’s disease, even though the antisense oligonucleotide...
Fosun secures rights to Aribio’s AR-1001 in potential $4.7B deal
BioWorld
Shanghai Fosun Pharmaceutical (Group) Co. Ltd. is paying $60 million up front for an option to secure exclusive rights to Aribio Co. Ltd.’s oral phase III-stage...